Morimoto M - Search Results

1

Risk of thoracic soft tissue sarcoma after breast cancer radiotherapy: a population-based cohort study in Osaka, Japan.

Ikawa T, Kuwabara Y, Nakata K, Kanayama N, Morimoto M, Miyashiro I, Konishi K. Ikawa T, et al. Among authors: morimoto m. J Radiat Res. 2024 May 23;65(3):272-278. doi: 10.1093/jrr/rrae010. J Radiat Res. 2024. PMID: 38515338 Free PMC article.

2

Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.

Fukuda S, Seo Y, Shiomi H, Yamada Y, Ogata T, Morimoto M, Konishi K, Yoshioka Y, Ogawa K. Fukuda S, et al. Among authors: morimoto m. J Radiat Res. 2014 Nov;55(6):1114-21. doi: 10.1093/jrr/rru048. Epub 2014 Jun 23. J Radiat Res. 2014. PMID: 24957754 Free PMC article.

3

Radiation Dose Escalation in Accelerated Hyperfractionated Radiotherapy for Stage III Non-small-cell Lung Cancer.

Wada K, Kishi N, Kanayama N, Hirata T, Morimoto M, Konishi K, Imamura F, Teshima T, Ogawa K. Wada K, et al. Among authors: morimoto m. Anticancer Res. 2018 Oct;38(10):5951-5958. doi: 10.21873/anticanres.12941. Anticancer Res. 2018. PMID: 30275224 Clinical Trial.

4

Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma.

Ikawa T, Ishihara R, Konishi K, Morimoto M, Hirata T, Kanayama N, Yamamoto S, Matsuura N, Wada K, Hayashi K, Ogawa K, Teshima T. Ikawa T, et al. Among authors: morimoto m. Cancer Med. 2019 Aug;8(10):4547-4554. doi: 10.1002/cam4.2365. Epub 2019 Jun 20. Cancer Med. 2019. PMID: 31222974 Free PMC article.

5

Kanayama N, Otozai S, Yoshii T, Toratani M, Ikawa T, Wada K, Hirata T, Morimoto M, Konishi K, Ogawa K, Fujii T, Teshima T. Kanayama N, et al. Among authors: morimoto m. Radiother Oncol. 2020 Oct;151:266-272. doi: 10.1016/j.radonc.2020.08.015. Epub 2020 Aug 29. Radiother Oncol. 2020. PMID: 32866561 Free article.

6

Prolonged overall treatment time negatively affects the outcomes of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: A propensity score-weighted, single-center analysis.

Ikawa T, Tabuchi T, Konishi K, Morimoto M, Hirata T, Kanayama N, Wada K, Toratani M, Okawa S, Ogawa K, Teshima T. Ikawa T, et al. Among authors: morimoto m. PLoS One. 2021 Jun 18;16(6):e0253203. doi: 10.1371/journal.pone.0253203. eCollection 2021. PLoS One. 2021. PMID: 34143851 Free PMC article.

7

Influence of radiation dose and predicted tumor invasion depth on local recurrence after definitive chemoradiotherapy for stage 0-I esophageal squamous cell carcinoma: a propensity score-weighted, retrospective, observational study.

Ikawa T, Ishihara R, Matsueda K, Konishi K, Yamamoto S, Morimoto M, Kanayama N, Teshima T. Ikawa T, et al. Among authors: morimoto m. BMC Cancer. 2022 Mar 21;22(1):301. doi: 10.1186/s12885-022-09418-2. BMC Cancer. 2022. PMID: 35313853 Free PMC article.

8

Linear accelerator-based stereotactic radiotherapy for brain metastases, including multiple and large lesions, carries a low incidence of acute toxicities: a retrospective analysis.

Ikawa T, Kanayama N, Arita H, Ohira S, Takano K, Hirata T, Morimoto M, Teshima T, Konishi K. Ikawa T, et al. Among authors: morimoto m. Radiat Oncol. 2023 May 10;18(1):80. doi: 10.1186/s13014-023-02262-z. Radiat Oncol. 2023. PMID: 37165431 Free PMC article.

9

Outcomes in patients with high- and very high-risk localized prostate cancer treated with definitive IMRT and long-term hormone therapy.

Kawamura N, Hayashi T, Nagahara A, Nakai Y, Nakayama M, Ikawa T, Kanayama N, Morimoto M, Konishi K, Nishimura K. Kawamura N, et al. Among authors: morimoto m. Jpn J Clin Oncol. 2024 Mar 9;54(3):346-351. doi: 10.1093/jjco/hyad178. Jpn J Clin Oncol. 2024. PMID: 38146119

10

Predictors of Acute Radiation Esophagitis in Non-small Cell Lung Cancer Patients Treated With Accelerated Hyperfractionated Chemoradiotherapy.

Wada K, Kishi N, Kanayama N, Hirata T, Ueda Y, Kawaguchi Y, Morimoto M, Konishi K, Imamura F, Ogawa K, Teshima T. Wada K, et al. Among authors: morimoto m. Anticancer Res. 2019 Jan;39(1):491-497. doi: 10.21873/anticanres.13139. Anticancer Res. 2019. PMID: 30591500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,710 results

Search Page